Molecular Partners Ag Stock Statistic Functions Linear Regression Intercept

MOLN Stock  USD 3.60  0.05  1.37%   
Molecular Partners statistic functions tool provides the execution environment for running the Linear Regression Intercept function and other technical functions against Molecular Partners. Molecular Partners value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Linear Regression Intercept function function is designed to identify and follow existing trends. Molecular Partners statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

Function
Time Period
Execute Function
The output start index for this execution was eleven with a total number of output elements of fifty. The Linear Regression Intercept is the expected mean value of Molecular Partners price seriese where values of its benchmark or peer price series are zero.

Molecular Partners Technical Analysis Modules

Most technical analysis of Molecular Partners help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Molecular from various momentum indicators to cycle indicators. When you analyze Molecular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Molecular Partners Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Molecular Partners AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Molecular Partners AG based on widely used predictive technical indicators. In general, we focus on analyzing Molecular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Molecular Partners's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Molecular Partners's intrinsic value. In addition to deriving basic predictive indicators for Molecular Partners, we also check how macroeconomic factors affect Molecular Partners price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 2025 (projected)
Days Sales Outstanding3.2790.581.4577.37
PTB Ratio0.850.640.980.93
Hype
Prediction
LowEstimatedHigh
0.183.607.40
Details
Intrinsic
Valuation
LowRealHigh
1.515.319.11
Details
Naive
Forecast
LowNextHigh
0.073.587.38
Details
4 Analysts
Consensus
LowTargetHigh
9.8910.8712.06
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Molecular Partners in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Molecular Partners' short interest history, or implied volatility extrapolated from Molecular Partners options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 30 shares
Cash Cows Idea
Cash Cows
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Chemicals Idea
Chemicals
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
When determining whether Molecular Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molecular Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molecular Partners Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molecular Partners Ag Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.12)
Revenue Per Share
0.146
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.21)
Return On Equity
(0.34)
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.